Measuring frailty in younger populations: a rapid review of evidence

Abstract

ObjectivesFrailty is typically assessed in older populations. Identifying frailty in adults aged under 60 years may also have value, if it supports the delivery of timely care. We sought to identify how frailty is measured in younger populations, including evidence of the impact on patient outcomes and care.DesignA rapid review of primary studies was conducted.Data sourcesFour databases, three sources of grey literature and reference lists of systematic reviews were searched in March 2020.Eligibility criteriaEligible studies measured frailty in populations aged under 60 years using experimental or observational designs, published after 2000 in English.Data extraction and synthesisRecords were screened against review criteria. Study data were extracted with 20% of records checked for accuracy by a second researcher. Data were synthesised using a narrative approach.ResultsWe identified 268 studies that measured frailty in samples that included people aged under 60 years. Of these, 85 studies reported evidence about measure validity. No measures were identified that were designed and validated to identify frailty exclusively in younger groups. However, in populations that included people aged over and under 60 years, cumulative deficit frailty indices, phenotype measures, the FRAIL Scale, the Liver Frailty Index and the Short Physical Performance Battery all demonstrated predictive validity for mortality and/or hospital admission. Evidence of criterion validity was rare. The extent to which measures possess validity across the younger adult age (18–59 years) spectrum was unclear. There was no evidence about the impact of measuring frailty in younger populations on patient outcomes and care.ConclusionsLimited evidence suggests that frailty measures have predictive validity in younger populations. Further research is needed to clarify the validity of measures across the adult age spectrum, and explore the utility of measuring frailty in younger groups.

Frailty in Parkinson’s disease: A systematic review and meta-analysis

“…Despite this limitation, frailty is not exclusive to older age groups and there would likely be benefit to identification and management of frailty in younger persons with PD. That being said, a recent review of frailty screening in populations <60 years determined that further study is needed around the validity of frailty screening measures, and the utility of identifying frailty in younger age groups [42] .…”

Handgrip strength predicts length of hospital stay in an abdominal surgical setting: the role of frailty beyond age

“…Identifying frailty in adults aged under 65 years may have crucial value, if it supports the delivery of timely care as in a surgical setting. In populations that included people aged over and under 60 years, Fried frailty phenotype demonstrated predictive validity [ 21 ]. Thus, subjects were divided into three groups according to Fried’s criteria for frailty [ 22 ].…”

Exploring the Relationship between Frailty, Functional Status, Polypharmacy, and Quality of Life in Elderly and Middle-Aged Patients with Cardiovascular Diseases: A One-Year Follow-Up Study

“…Due to the negative health outcomes associated with frailty, routine screening and studies have been applied and recommended to populations aged over 65 years [ 11 , 12 , 13 , 14 , 15 ], but there is limited data available regarding middle-aged populations (45–65 years old) or those younger than 45 years old [ 16 , 17 ].…”